(Q39264265)

10 September 2017

0 references

Probiotic and synbiotic safety in infants under two years of age. (English)

1 reference

10 September 2017

0 references

4

1 reference

10 September 2017

5

1 reference

10 September 2017

L Morelli

3

0 references

author name string

M van den Nieuwboer

series ordinal

1

1 reference

10 September 2017

E Claassen

series ordinal

2

1 reference

10 September 2017

publication date

1 March 2014

1 reference

10 September 2017

1 reference

10 September 2017

volume

5

1 reference

10 September 2017

issue

1

1 reference

10 September 2017

page(s)

45-60

1 reference

A Th1/Th2-associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization.

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Probiotic lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Probiotics-supplemented feeding in extremely low-birth-weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Efficacy of high-dose Lactobacillus rhamnosus GG in controlling acute watery diarrhea in Indian children: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

The impact of the gut microbiota on human health: an integrative view

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Probiotics, prebiotics, and synbiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Probiotics in the prevention of necrotizing enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Safety of supplementing infant formula with long-chain polyunsaturated fatty acids and Bifidobacterium lactis in term infants: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Urinary D-lactate excretion in infants receiving Lactobacillus johnsonii with formula

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Probiotics in neonatology

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Lactobacillus reuteri accelerates gastric emptying and improves regurgitation in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Control of pathogens and pathobionts by the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Predominant genera of fecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bi-07.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Prevention of necrotizing enterocolitis in preterm very low birth weight infants: is it feasible?

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Prevention of allergy in infants of allergic mothers by probiotic Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Strain-dependent effects of probiotic lactobacilli on EAE autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Human milk probiotic Lactobacillus fermentum CECT5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Innate cellular immune responses in newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Interaction of orally administered Lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

The effects of selected probiotic strains on the development of eczema (the PandA study).

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Prenatal and postnatal probiotics reduces maternal but not childhood allergic diseases: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Long-term colonization of a Lactobacillus plantarum synbiotic preparation in the neonatal gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Effects of feeding an infant formula containing Lactobacillus GG on the colonization of the intestine: a dose-response study in healthy infants

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

FAO Technical meeting on prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

The germfree murine animal: an important animal model for research on the relationship between gut microbiota and the host

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Efficacy of Lactobacillus GG in aboriginal children with acute diarrhoeal disease: a randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Cow's milk allergy is associated with changes in urinary organic acid concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Safety assessment of probiotics for human use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

An update on the use and investigation of probiotics in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Do oral probiotics affect growth and neurodevelopmental outcomes in very low-birth-weight preterm infants?

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Growth and tolerance of healthy term infants receiving hydrolyzed infant formulas supplemented with Lactobacillus rhamnosus GG: randomized, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhea in children: a randomized, single-blind, controlled trial in Bolivian children

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Growth and metabolism of infants born to women infected with human immunodeficiency virus and fed acidified whey-adapted starter formulas

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Tolerance and safety of Lactobacillus paracasei ssp. paracasei in combination with Bifidobacterium animalis ssp. lactis in a prebiotic-containing infant formula: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Regulating the safety of probiotics--the European approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Probiotics, prebiotics, and synbiotics: gut and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Probiotics during weaning reduce the incidence of eczema.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Effects of probiotics on atopic dermatitis: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Effect of Bifidobacterium administration on very-low-birthweight infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Probiotics and the immunological response to infant vaccinations: a prospective, placebo controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Probiotic supplementation in the first 6 months of life in at risk Asian infants - effects on eczema and atopic sensitization at the age of 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant Hepatitis B vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Prophylactic Probiotics to Prevent Death and Nosocomial Infection in Preterm Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

Lactobacillus GG Improves Recovery in Infants with Blood in the Stools and Presumptive Allergic Colitis Compared with Extensively Hydrolyzed Formula Alone

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2013.0046

21 January 2018

Identifiers

DOI

10.3920/BM2013.0046

1 reference

10 September 2017

1 reference